Leukemia · 2013 · 62 citations · 41 references
Life SciencesMolecular BiologyOncologyApoptosisGene ExpressionMolecular OncologyBcl-2 Family ProteinsCancer TranscriptomicsGene Fusions In CancerMicrorna BiogenesisMicrorna-mediated RegulationAllogeneic Stem Cell TherapyB-cell Acute Lymphoblastic LeukemiaBcl-2 Protein ExpressionBcr-abl DependenceLeukemia-associated Fusion GenesMicrorna In ApoptosisTherapeutic Target IdentificationTherapeutic Target Validation
Despite advances in allogeneic stem cell transplantation, BCR-ABL-positive acute lymphoblastic leukaemia (ALL) remains a high-risk disease, necessitating the development of novel treatment strategies. As the known oncomir, miR-17~92, is regulated by BCR-ABL fusion in chronic myeloid leukaemia, we investigated its role in BCR-ABL translocated ALL. miR-17~92-encoded miRNAs were significantly less abundant in BCR-ABL-positive as compared to -negative ALL-cells and overexpression of miR-17~19b triggered apoptosis in a BCR-ABL-dependent manner. Stable isotope labelling of amino acids in culture (SILAC) followed by liquid chromatography and mass spectroscopy (LC-MS) identified several apoptosis-related proteins including Bcl2 as potential targets of miR-17~19b. We validated Bcl2 as a direct target of this miRNA cluster in mice and humans, and, similar to miR-17~19b overexpression, Bcl2-specific RNAi strongly induced apoptosis in BCR-ABL-positive cells. Furthermore, BCR-ABL-positive human ALL cell lines were more sensitive to pharmacological BCL2 inhibition than negative ones. Finally, in a xenograft model using patient-derived leukaemic blasts, real-time, in vivo imaging confirmed pharmacological inhibition of BCL2 as a new therapeutic strategy in BCR-ABL-positive ALL. These data demonstrate the role of miR-17~92 in regulation of apoptosis, and identify BCL2 as a therapeutic target of particular relevance in BCR-ABL-positive ALL.
41
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Tilman Oltersdorf, Steven W. Elmore, Alexander R. Shoemaker et al. · Nature · 2005 · 3.4K citations
c-Myc-regulated microRNAs modulate E2F1 expression
Kathryn A. O’Donnell, Erik A. Wentzel, Karen Zeller et al. · Nature · 2005 · 2.6K citations